logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Joshua Tobias

university of gothenburg
H指数:25
被引数:1,898

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Final results of the phase II trial of HER-Vaxx, a B-cell peptide-based vaccine plus standard care of chemotherapy in patients with HER2-overexpressing advanced gastric cancer - (HERIZON)

HER-Vaxx II期临床试验的最终结果，该试验采用基于B细胞肽的疫苗联合化疗标准治疗方案，用于HER2过表达的晚期胃癌患者 - (HERIZON)

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Tobias, J.; Kundi, M.; Garner-Spitzer, E.; Zielinski, C. C.; Maglakelidze, M.; Andric, Z. G.; Petrovic, Z.; Nikolic, I. V.; Ryspayeva, D.; Bulat, I. V.; Nagarkar, R.; Chawla, T.; Chong, L. O.; Nixon, B.; Yavrom, S.; Ede, N. J.; Wiedermann, U.
Frontline vaccination with the B-cell peptide compound HER-Vaxx (IMU-131), combined with standard-of-care chemotherapy induces high levels of HER2-specific antibodies mediating ADCC and intracellular phosphorylation inhibition resulting in overall survival benefit in patients with HER2+metastatic or advanced gastric/GEJ adenocarcinoma - Final results from Phase II/HERIZON study
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Tobias, Joshua; Kundi, Michael; Garner-Spitzer, Erika; Zielinski, Christoph; Maglakelidze, Marina; Andric, Zoran; Petrovic, Zoran; Nagarkar, Rajnish; Chawla, Tanuj; Chong, Leslie Mi Ok; Nixon, Bonnie; Yavrom, Sharon; Ede, Nicholas J.; Wiedermann, Ursula

研究方向

暂未获取到该数据
U
Ursula Wiedermann
H 指数:45论文数:328被引数:6,559
M
Michael Kundi
H 指数:78论文数:696被引数:2.4万
C
Christoph Zielinski
H 指数:82论文数:1,019被引数:3.0万
E
Erika Garner‐Spitzer
H 指数:17论文数:89被引数:1,029
M
Mirjana Drinić
H 指数:9论文数:45被引数:269
A
Ann‐Mari Svennerholm
H 指数:66论文数:345被引数:1.3万
P
Peter Steinberger
H 指数:48论文数:223被引数:7,118
M
Michael Lebens
H 指数:32论文数:77被引数:3,350
J
Jan Holmgren
H 指数:98论文数:591被引数:3.3万
Å
Åsa Sjöling
H 指数:35论文数:117被引数:3,589